Lung Institute

Factors for Success and Failure of Allergen Immunotherapy ( AIT ) Trial Design in the Light of Evidence‐Based Medicine: Current Aspects 2026

Allergen immunotherapy (AIT) has been acknowledged as the only disease-modifying treatment for respiratory diseases since its introduction in 1911. Although the efficacy and safety have convincingly been established in numerous randomized clinical trials (RCTs), the AIT study res...

PrEP awareness, barriers and facilitators in Malaysia in the current landscape of new HIV infections: a review

Pre-exposure prophylaxis (PrEP) uptake remains low among key populations in Malaysia despite notable improvements in PrEP awareness. This literature review aims to understand PrEP awareness, barriers and facilitators that influence PrEP utilisation. PrEP awareness ranged between...